Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2,431.97%-173.14K | -78.50%-48.57K | -506.07%-42K | -33.89%-110.67K | -205.45%-86.97K | 82.69%-6.84K | 34.80%-27.21K | 112.33%10.34K | 72.64%-82.66K | 197.67%82.48K |
| Net income from continuing operations | -657.29%-182.47K | -515.05%-100.94K | -199.89%-142.91K | 44.71%-115.96K | 68.47%-27.8K | 25.59%-24.1K | 50.34%-16.41K | 15.14%-47.65K | 15.58%-209.74K | -78.86%-88.15K |
| Unrealized gains and losses of investment securities | --0 | ---3.33K | -211.88%-1.05K | -15.15%1.95K | -63.21%1.02K | --0 | --0 | -75.07%934 | -54.06%2.3K | -44.82%2.76K |
| Remuneration paid in stock | --0 | --0 | --92.4K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cashItems | ---1 | ---- | ---- | -141.48%-71.23K | ---35.25K | --0 | ---- | ---- | ---29.5K | --0 |
| Change In working capital | -45.92%9.33K | 156.64%64.65K | -83.27%9.55K | -51.67%74.57K | -114.86%-24.94K | 342.10%17.26K | 0.64%25.19K | 281.21%57.06K | 362.74%154.28K | 518.01%167.87K |
| -Change in receivables | -3,437.17%-26.66K | 82.10%8.84K | -215.35%-14.44K | 12.43%7.41K | 5.62%-10.76K | 110.95%799 | -87.14%4.86K | 200.36%12.52K | 124.04%6.59K | -12.92%-11.41K |
| -Change in prepaid assets | --8.72K | ---19.33K | 58.19%5.75K | -206.59%-9.57K | -208.90%-13.21K | --0 | --0 | 155.61%3.63K | 2,666.29%8.98K | 120.63%12.13K |
| -Change in payables and accrued expense | 65.72%27.28K | 269.52%75.14K | -55.42%18.24K | -44.68%76.74K | -100.58%-967 | 610.32%16.46K | 211.29%20.33K | 427.71%40.91K | 547.99%138.71K | 570.09%167.15K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2,431.98%-173.14K | -78.50%-48.57K | -506.07%-42K | -33.89%-110.67K | -205.45%-86.97K | 82.69%-6.84K | 34.80%-27.21K | 112.33%10.34K | 72.64%-82.66K | 197.67%82.48K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -950.33%-141.72K | -9.74K | -1,662.02%-56.74K | 111.77%16.19K | 102.52%2.74K | 191.42%16.67K | 0 | 87.03%-3.22K | 58.08%-137.58K | -338.12%-108.77K |
| Net PPE purchase and sale | -950.33%-141.72K | ---9.74K | -1,662.02%-56.74K | 111.77%16.19K | 102.52%2.74K | 191.42%16.67K | --0 | 87.03%-3.22K | 58.08%-137.58K | -338.12%-108.77K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -950.33%-141.72K | ---9.74K | -1,662.02%-56.74K | 111.77%16.19K | 102.52%2.74K | 191.42%16.67K | --0 | 87.03%-3.22K | 58.08%-137.58K | -338.12%-108.77K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 796.00%545.48K | 155.12%227.69K | 2,539.74%166.81K | 5.80%60.88K | -86.94%89.25K | -92.59%6.32K | ||||
| Net common stock issuance | 710.26%568.8K | ---- | ---- | 328.17%274.2K | --204K | --70.2K | ---- | ---- | -91.60%64.04K | --0 |
| Net other financing activities | ---23.32K | ---- | ---- | -284.54%-46.52K | -688.62%-37.2K | ---- | ---- | ---- | 132.15%25.21K | 159.15%6.32K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 796.00%545.48K | ---- | ---- | 155.12%227.69K | 2,539.74%166.81K | 5.80%60.88K | ---- | ---- | -86.94%89.25K | -92.59%6.32K |
| Net cash flow | ||||||||||
| Beginning cash position | 27,496.12%476.86K | 94.46%56.27K | 610.64%155.01K | -85.72%21.81K | 73.34%72.44K | -95.88%1.73K | -39.51%28.94K | -85.72%21.81K | 53.52%152.8K | -76.36%41.79K |
| Current changes in cash | 226.16%230.62K | 1,645.78%420.59K | -1,486.03%-98.74K | 201.69%133.2K | 513.39%82.58K | 35,811.62%70.71K | -364.95%-27.21K | 106.79%7.12K | -345.89%-130.99K | 16.75%-19.98K |
| End cash Position | 876.69%707.48K | 27,496.12%476.86K | 94.46%56.27K | 610.64%155.01K | 610.64%155.01K | 73.34%72.44K | -95.88%1.73K | -39.51%28.94K | -85.72%21.81K | -85.72%21.81K |
| Free cash from | -4,504.58%-314.86K | -114.29%-58.31K | -1,486.03%-98.74K | 49.53%-111.15K | -220.35%-84.23K | 88.16%-6.84K | 1.00%-27.21K | 106.55%7.12K | 65.06%-220.24K | 75.94%-26.29K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.